Oncogenes enhance the expression of cyclooxygenase (Cox)-2, but interaction
s between tumor suppressor genes and Cox-a have not been studied. In the pr
esent work, we have compared the levels of Cox-2 and the production of pros
taglandin E-2 in mouse embryo fibroblasts that do not express any p53 ((10)
1) versus the same cell line ((10.1)Val5) engineered to overexpress wild-ty
pe (wt) p53 at 32 degrees C or mutant p53 at 39 degrees C. Cells expressing
wt p53 showed about a 10-fold decrease in synthesis of prostaglandin E-2 c
ompared with those expressing mutant p53. Levels of Cox-2 protein and mRNA
were markedly suppressed by wt p53 but not by mutant p53. Nuclear run-offs
revealed decreased rates of Cox-2 transcription in cells expressing wt p53.
The activity of the Cox-2 promoter was reduced by 85% in cells expressing
wt p53 but was reduced only by 30% in cells express ing mutant p53 compared
with cells null for p53. The effect of p53 on the suppression of Cox-2 pro
moter activity was localized to the first 40 base pairs 5' from the transcr
iption start site. Electrophoretic mobility shift assay revealed that p53 c
ompeted with TATA-binding protein for binding to mouse Cox-2 or human Cox-2
promoter extending from -50 to +52 base pairs. The results of this study s
uggest that interactions between p53 and Cox-2 could be important for under
standing why levels of Cox-2 are undetectable in normal cells and increased
in many tumors.